These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.
Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
Injection, von willebrand factor complex (humate-p), per iu vwf:rco
Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
Factor viii (antihemophilic factor, human) per i.u.
Factor viii (antihemophilic factor (porcine)), per i.u.
Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.
Factor ix, complex, per i.u.
Continued
Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
Injection, antithrombin recombinant, 50 i.u.
Antithrombin iii (human), per i.u.
Anti-inhibitor, per i.u.
Hemophilia clotting factor, not otherwise classified
Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu
Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.
Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
Injection, factor viii fc fusion protein (recombinant), per iu
Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.
Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.
Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
Continued
Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
Intrauterine copper contraceptive (miudella)
Intrauterine copper contraceptive (paragard)
Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
Contraceptive supply, hormone containing vaginal ring, each
Contraceptive supply, hormone containing patch, each
Levonorgestrel (contraceptive) implant system, including implants and supplies
Etonogestrel (contraceptive) implant system, including implant and supplies
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
Ganciclovir, 4.5 mg, long-acting implant
Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
Injection, dexamethasone, intravitreal implant, 0.1 mg
Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
Mitomycin, ophthalmic, 0.2 mg